vc004
Small moleculeexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Nov 20, 2020 (NCT04614740)
Timeline
Indications
Mechanism of action
- Nerve growth factor receptor Trk-AANTAGONIST
NTRK1 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06658353 | Phase 3 | Nov 20, 2024 | Jiangsu vcare pharmaceutical technology co., LTD, Peking University |
| NCT06619951 | Phase 1 | Oct 30, 2024 | Jiangsu vcare pharmaceutical technology co., LTD, Southeast University |
| NCT06529445 | Phase 1 | Jul 22, 2024 | Jiangsu vcare pharmaceutical technology co., LTD |
| NCT05528120 | Phase 1 | Oct 20, 2022 | Jiangsu vcare pharmaceutical technology co., LTD |
| NCT04614740 | Phase 1/Phase 2 (Phase 2) | Nov 20, 2020 | Jiangsu vcare pharmaceutical technology co., LTD, Peking University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu vcare pharmaceutical technology co., LTD | For profit | 5 | 5 | 3 | 2020 |
| Peking University | Academic/Hospital | 2 | 0 | 2 | 2020 |
| Southeast University | Academic/Hospital | 1 | 0 | 1 | 2024 |
3 organizations
Page 1 / 1